The researchers commented that given that the U.S. Food and Drug Administration permits most medications marketed in the United States to contain 90% to 110% of the labeled concentration of the active ingredients, in the setting of outpatient anaphylaxis without other therapeutic alternatives, patients and caregivers should consider the potential benefits of using an expired EpiPen.